KPU-300, a Novel Benzophenone–Diketopiperazine–Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
KPU-300, a Novel Benzophenone–Diketopiperazine–Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase
Authors
Keywords
Drug therapy, Cell cycle and cell division, Fluorescence imaging, Fluorescence microscopy, Cancer treatment, G1 phase, Cell disruption, Fluorescence
Journal
PLoS One
Volume 10, Issue 12, Pages e0145995
Publisher
Public Library of Science (PLoS)
Online
2015-12-31
DOI
10.1371/journal.pone.0145995
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins
- (2015) Marianne S. Poruchynsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of X-Irradiation at Different Stages in the Cell Cycle on Individual Cell–Based Kinetics in an Asynchronous Cell Population
- (2015) Eri Tsuchida et al. PLoS One
- Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity
- (2015) Shuya Yano et al. Oncotarget
- The Quest for a Simple Bioactive Analog of Paclitaxel as a Potential Anticancer Agent
- (2014) David G. I. Kingston et al. ACCOUNTS OF CHEMICAL RESEARCH
- Tumor-targetingSalmonella typhimuriumA1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy
- (2014) Shuya Yano et al. CELL CYCLE
- The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation
- (2014) April L Risinger et al. Molecular Cancer
- Development of a New Benzophenone–Diketopiperazine-Type Potent Antimicrotubule Agent Possessing a 2-Pyridine Structure
- (2014) Yoshiki Hayashi et al. ACS Medicinal Chemistry Letters
- Taxanes as radiosensitizers
- (2013) Encouse B. Golden et al. ANTI-CANCER DRUGS
- Visualizing the effect of tumor microenvironments on radiation-induced cell kinetics in multicellular spheroids consisting of HeLa cells
- (2013) Atsushi Kaida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Thymoquinone inhibits microtubule polymerization by tubulin binding and causes mitotic arrest following apoptosis in A549 cells
- (2013) Bipul R. Acharya et al. BIOCHIMIE
- Cabazitaxel-Induced Stabilization of Microtubules Enhances Radiosensitivity in Ovarian Cancer Cells
- (2013) Charles A. Kunos et al. Frontiers in Oncology
- Unusual expression of red fluorescence at M phase induced by anti-microtubule agents in HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci)
- (2012) Asumi Honda-Uezono et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments
- (2012) Linh Nguyen et al. BMC CANCER
- Combretastatin A-4 Phosphate Affects Tumor Vessel Volume and Size Distribution as Assessed Using MRI-Based Vessel Size Imaging
- (2012) T. Nielsen et al. CLINICAL CANCER RESEARCH
- Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of Radiotherapy
- (2011) Michael E. Werner et al. ACS Nano
- Give me a break, but not in mitosis
- (2011) Simona Giunta et al. CELL CYCLE
- A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy
- (2011) Bart J. Crielaard et al. International Journal of Nanomedicine
- Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel
- (2011) Michael Millward et al. INVESTIGATIONAL NEW DRUGS
- Synthesis and Structure–Activity Relationship Study of Antimicrotubule Agents Phenylahistin Derivatives with a Didehydropiperazine-2,5-dione Structure
- (2011) Yuri Yamazaki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Radiosensitivity of Early and Late M-Phase HeLa Cells Isolated by a Combination of Fluorescent Ubiquitination-Based Cell Cycle Indicator (Fucci) and Mitotic Shake-Off
- (2011) Motoshi Nakayama et al. RADIATION RESEARCH
- Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas
- (2010) M. M. Mita et al. CLINICAL CANCER RESEARCH
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
- (2008) Asako Sakaue-Sawano et al. CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started